Got some exciting products in their pipeline. Also adds to the diversification of this wikifolio in terms of the scope of medicine. But since their cash flow is negative, I do not want to load up a big chunk. Their current Beta is just appropriate to spice this portfolio up as I intend to mix big pharma players and smaller ones I find promising.
Thanks for still sticking with me and this portfolio!mehr anzeigen